Free Trial
→ Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry.' (From Brownstone Research) (Ad) Free AKTX Stock Alerts

Akari Therapeutics (AKTX) Short Interest Ratio & Short Volume

Akari Therapeutics logo
$0.90 -0.03 (-2.74%)
As of 03/13/2025 04:00 PM Eastern
This is a fair market value price provided by Polygon.io. Learn more.
Compare

Akari Therapeutics Short Interest Data

Akari Therapeutics (AKTX) has a short interest of 77,300 shares, representing 0.64% of the float (the number of shares available for trading by the public). This marks a -0.51% decrease in short interest from the previous month. The short interest ratio (days to cover) is 1.7, indicating that it would take 1.7 days of the average trading volume of 35,281 shares to cover all short positions.

Current Short Interest
77,300 shares
Previous Short Interest
77,700 shares
Change Vs. Previous Month
-0.51%
Dollar Volume Sold Short
$67,251.00
Short Interest Ratio
1.7 Days to Cover
Last Record Date
February 28, 2025
Outstanding Shares
26,593,000 shares
Float Size
12,100,000 shares
Short Percent of Float
0.64%
Today's Trading Volume
12,001 shares
Average Trading Volume
35,281 shares
Today's Volume Vs. Average
34%
Short Selling Akari Therapeutics?
cover of A Guide to High-Short-Interest Stocks and How to Trade Them ebook

Sign up to receive the latest short interest report for Akari Therapeutics and its competitors with MarketBeat's FREE newsletter.

Skip Charts & View Short Interest History
Short Interest ChartDays to Cover ChartShort Percent of Float Chart

AKTX Short Interest Over Time

AKTX Days to Cover Over Time

AKTX Percentage of Float Shorted Over Time

Remove Ads

Akari Therapeutics Short Interest History

Export to Excel
Report DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date
2/28/202577,300 shares $67,251.00 -0.5%0.6%1.7 $0.87
2/15/202577,700 shares $84,226.80 -38.7%0.6%1.4 $1.08
1/31/2025126,800 shares $138,212.00 -0.5%1.1%2.2 $1.09
1/15/2025127,400 shares $159,250.00 -11.7%1.1%2.3 $1.25
12/31/2024144,200 shares $175,924.00 +94.6%1.2%2.6 $1.22
12/15/202474,100 shares $72,099.30 +30.2%0.6%1.7 $0.97
11/30/202456,900 shares $68,849.00 +151.8%0.5%1.6 $1.21
11/15/202422,600 shares $47,008.00 +6.1%0.2%0.7 $2.08
10/31/202421,300 shares $51,120.00 +15.1%0.2%1.3 $2.40
10/15/202418,500 shares $47,191.65 -52.7%0.2%1.1 $2.55
9/30/202439,100 shares $115,345.00 -3.9%0.3%2.1 $2.95
9/15/202440,700 shares $132,478.50 +4.4%0.3%2.4 $3.26
8/31/202439,000 shares $149,370.00 +33.6%0.3%1.8 $3.83
8/15/202429,200 shares $93,440.00 +17.7%0.2%1.2 $3.20
7/31/202424,800 shares $92,504.00 -0.4%0.3%1 $3.73
7/15/202424,900 shares $93,126.00 +236.5%0.3%1 $3.74
6/30/20247,400 shares $19,980.00 -53.2%0.1%0.3 $2.70
6/15/202415,800 shares $49,928.00 -26.9%0.2%0.6 $3.16
5/31/202421,600 shares $38,880.00 +71.4%0.3%0.9 $1.80
5/15/202412,600 shares $18,396.00 +472.7%0.2%0.7 $1.46
4/30/20242,200 shares $3,388.00 +266.7%0.0%0.1 $1.54
4/15/2024600 shares $720.00 -94.3%0.0%0.1 $1.20
3/31/202410,500 shares $19,582.50 +75.0%0.2%0.9 $1.87
3/15/20246,000 shares $11,820.00 -37.5%0.1%0.6 $1.97
2/29/20249,600 shares $21,216.00 +10.3%0.2%1.1 $2.21
2/15/20248,700 shares $20,706.00 +357.9%0.2%1 $2.38
1/31/20241,900 shares $4,807.00 -66.7%0.0%0.2 $2.53
1/15/20245,700 shares $16,416.00 +375.0%0.1%0.5 $2.88
12/31/20231,200 shares $3,744.00 -29.4%0.0%0.1 $3.12
12/15/20231,700 shares $4,760.00 -50.0%0.0%0.1 $2.80
11/30/20233,400 shares $10,030.00 -69.6%0.1%0.3 $2.95
11/15/202311,200 shares $35,504.00 -36.0%0.2%0.7 $3.17
10/31/202317,500 shares $61,425.00 +49.6%0.4%0.8 $3.51
10/15/202311,700 shares $42,705.00 -33.5%0.2%0.4 $3.65
9/30/202317,600 shares $69,520.00 +2.9%0.4%0.7 $3.95
9/15/202317,100 shares $62,244.00 +116.5%0.5%0.6 $3.64
8/31/20237,900 shares $24,885.00 -24.8%0.2%0.3 $3.15
8/15/202310,500 shares $39,585.00 -95.7%0.3%0.3 $3.77
7/31/2023243,800 shares $60,852.48 -29.2%N/A0.5 $0.25
7/15/2023344,200 shares $58,961.46 +67.3%N/A0.6 $0.17
A deadly mistake in my prediction… (Ad)

I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we are, a quarter of a century later, almost to the exact day, and it’s happening again.

Here’s the full story for you.
6/30/2023205,700 shares $34,948.43 -1.5%N/A0.4 $0.17
6/15/2023208,800 shares $32,760.72 -3.7%N/A0.4 $0.16
5/31/2023216,700 shares $38,334.23 -5.2%N/A0.4 $0.18
5/15/2023228,600 shares $42,153.84 +104.5%N/A0.5 $0.18
4/30/2023111,800 shares $20,246.98 -62.3%N/A0.3 $0.18
4/15/2023296,900 shares $59,409.69 +128.0%N/A0.8 $0.20
3/31/2023130,200 shares $23,657.34 -21.5%N/A0.5 $0.18
3/15/2023165,800 shares $42,776.40 +79.4%N/A1.3 $0.26
2/28/202392,400 shares $31,878.00 +42.2%N/A0.8 $0.35
2/15/202365,000 shares $29,250.00 -30.6%N/A0.7 $0.45
1/31/202393,700 shares $43,739.16 -15.9%N/A1.2 $0.47
1/15/2023111,400 shares $60,111.44 +47.2%N/A1.4 $0.54
12/30/202275,700 shares $35,571.43 -2.1%N/A0.9 $0.47
12/15/202277,300 shares $35,558.00 -43.0%N/A1 $0.46
11/30/2022135,500 shares $74,877.30 -8.2%N/A1.3 $0.55
11/15/2022147,600 shares $84,279.60 +313.5%N/A1.5 $0.57
10/31/202235,700 shares $16,629.06 -44.8%N/A0.4 $0.47
10/15/202264,700 shares $31,470.08 -16.8%N/A0.7 $0.49
9/30/202277,800 shares $49,014.00 +215.0%0.5%0.8 $0.63
9/15/202224,700 shares $16,796.00 -10.5%0.2%0.3 $0.68
8/31/202227,600 shares $32,844.00 -47.1%0.2%0.4 $1.19
8/15/202252,200 shares $78,300.00 +1,435.3%0.4%0.7 $1.50
7/31/20223,400 shares $3,876.00 -95.0%0.0%0 $1.14
7/15/202267,300 shares $56,585.84 -10.7%0.5%1.1 $0.84
6/30/202275,400 shares $75,400.00 -30.1%0.5%1.4 $1.00
6/15/2022107,900 shares $104,663.00 -16.6%0.8%2 $0.97
5/31/2022129,300 shares $151,281.00 +35.8%N/A2.1 $1.17
5/15/202295,200 shares $104,720.00 +12.4%N/A1.5 $1.10
4/30/202284,700 shares $100,793.00 +4.6%N/A1.2 $1.19
4/15/202281,000 shares $97,200.00 -13.0%N/A1.1 $1.20
3/31/202293,100 shares $111,720.00 -12.3%N/A1.2 $1.20
3/15/2022106,200 shares $117,351.00 +14.9%N/A1 $1.11
2/28/202292,400 shares $124,740.00 -3.3%N/A0.9 $1.35
2/15/202295,500 shares $146,115.00 +24.8%N/A1 $1.53
1/31/202276,500 shares $104,805.00 -11.1%N/A0.8 $1.37
1/15/202286,000 shares $124,700.00 -40.5%N/A0.8 $1.45
12/31/2021144,500 shares $216,750.00 +113.4%N/A1.3 $1.50
12/15/202167,700 shares $101,570.31 +129.5%N/A0.7 $1.50
11/30/202129,500 shares $48,085.00 +87.9%N/A0.3 $1.63
11/15/202115,700 shares $25,905.00 -74.4%N/A0.1 $1.65
10/29/202161,300 shares $101,758.00 +48.8%N/A0.6 $1.66
10/15/202141,200 shares $67,980.00 -11.0%N/A0.4 $1.65
9/30/202146,300 shares $75,469.00 -38.8%N/A0.4 $1.63
9/15/202175,700 shares $139,288.00 +90.7%N/A0.7 $1.84
8/31/202139,700 shares $73,048.00 -2.0%N/A0.3 $1.84
8/13/202140,500 shares $67,635.00 -17.9%N/A0.3 $1.67
7/30/202149,300 shares $79,866.00 -40.8%N/A0.3 $1.62
7/15/202183,200 shares $137,280.00 +51.6%N/A0.2 $1.65
6/30/202154,900 shares $94,977.00 -43.6%N/A0.1 $1.73
6/15/202197,300 shares $170,275.00 +72.5%N/A0.2 $1.75
DOGE could send 6 AI stocks through the roof (Ad)

Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement from Elon any day now … Thousands of government jobs could be replaced … By a new form of AI. Recently perfected by Musk and his team at xAI.

Click here to find out what DOGE's next move is.
5/28/202156,400 shares $101,238.00 -39.6%N/A0.1 $1.80
5/14/202193,300 shares $167,940.00 -59.2%N/A0.2 $1.80
4/30/2021228,400 shares $477,356.00 +217.7%N/A0.5 $2.09
4/15/202171,900 shares $154,585.00 +276.4%N/A0.3 $2.15
3/31/202119,100 shares $48,514.00 -77.3%N/A0.1 $2.54
3/15/202184,200 shares $262,704.00 +231.5%N/A0.4 $3.12
2/26/202125,400 shares $84,328.00 -28.1%N/A0.1 $3.32
2/12/202135,300 shares $96,016.00 -77.7%N/A0.1 $2.72
1/29/2021158,000 shares $379,200.00 -16.8%N/A0.6 $2.40
1/15/2021189,800 shares $482,092.00 +10.3%N/A0.7 $2.54
12/31/2020172,100 shares $313,222.00 +10.8%N/A0.9 $1.82
12/15/2020155,300 shares $301,282.00 +119.0%N/A0.9 $1.94
11/30/202070,900 shares $111,313.00 +24.8%N/A0.5 $1.57
11/15/202056,800 shares $92,016.00 -15.0%N/A0.4 $1.62
10/30/202066,800 shares $106,212.00 -39.6%N/A0.5 $1.59
10/15/2020110,500 shares $202,215.00 -29.8%N/A0.6 $1.83
9/30/2020157,400 shares $273,876.00 -42.1%N/A0.8 $1.74
9/15/2020272,000 shares $465,120.00 +19.5%N/A1 $1.71
8/31/2020227,700 shares $391,644.00 +3.6%N/A0.7 $1.72
8/14/2020219,700 shares $417,430.00 +34.6%N/A0.6 $1.90
7/31/2020163,200 shares $328,032.00 +4.0%N/A0.4 $2.01
7/15/2020157,000 shares $312,430.00 +90.1%N/A0.4 $1.99
6/30/202082,600 shares $186,676.00 -56.7%N/A0.2 $2.26
6/15/2020190,900 shares $376,073.00 +186.2%N/A0.7 $1.97
5/29/202066,700 shares $133,400.00 -35.8%N/A0.3 $2.00
5/15/2020103,900 shares $180,786.00 -11.1%N/A0.6 $1.74
4/30/2020116,900 shares $224,448.00 -11.1%N/A0.9 $1.92
4/15/2020131,500 shares $203,825.00 -33.6%N/A1.2 $1.55
3/31/2020198,100 shares $334,789.00 +45.7%N/A1 $1.69

AKTX Short Interest - Frequently Asked Questions

What is Akari Therapeutics' current short interest?

Short interest is the volume of Akari Therapeutics shares that have been sold short but have not yet been covered or closed out. As of February 28th, traders have sold 77,300 shares of AKTX short. 0.64% of Akari Therapeutics' shares are currently sold short. Learn More on Akari Therapeutics' current short interest.

What is a good short interest ratio for Akari Therapeutics?

The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. AKTX shares currently have a short interest ratio of 2.0. Learn More on Akari Therapeutics's short interest ratio.

What is a good short interest percentage for Akari Therapeutics?

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.64% of Akari Therapeutics' floating shares are currently sold short.

Is Akari Therapeutics' short interest increasing or decreasing?

Akari Therapeutics saw a decrease in short interest in February. As of February 28th, there was short interest totaling 77,300 shares, a decrease of 0.5% from the previous total of 77,700 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

What is Akari Therapeutics' float size?

Akari Therapeutics currently has issued a total of 26,593,000 shares. Some of Akari Therapeutics' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. Akari Therapeutics currently has a public float of 12,100,000 shares.

How does Akari Therapeutics' short interest compare to its competitors?

0.64% of Akari Therapeutics' shares are currently sold short. Here is how the short interest of companies in the industry of "pharmaceutical products" compare to Akari Therapeutics: Atossa Therapeutics, Inc. (7.62%), Cardiol Therapeutics Inc. (2.41%), Adverum Biotechnologies, Inc. (11.60%), Biomea Fusion, Inc. (35.09%), Alto Neuroscience, Inc. (16.15%), HilleVax, Inc. (7.16%), Adagene Inc. (0.05%), Pliant Therapeutics, Inc. (5.78%), Lexeo Therapeutics, Inc. (9.75%), Cabaletta Bio, Inc. (15.35%),

Which stocks are the most shorted right now?

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($23.74 billion), iShares 20+ Year Treasury Bond ETF ($10.75 billion), MicroStrategy Incorporated ($6.56 billion), Apollo Global Management, Inc. ($5.40 billion), Charter Communications, Inc. ($4.57 billion), AppLovin Co. ($4.45 billion), Capital One Financial Co. ($4.33 billion), Super Micro Computer, Inc. ($4.23 billion), Schlumberger Limited ($3.22 billion), and Royal Caribbean Cruises Ltd. ($3.06 billion). View all of the most shorted stocks.

What does it mean to sell short Akari Therapeutics stock?

Short selling AKTX is an investing strategy that aims to generate trading profit from Akari Therapeutics as its price is falling. AKTX shares are trading down $0.02 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

How does a short squeeze work against Akari Therapeutics?

A short squeeze for Akari Therapeutics occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of AKTX, which in turn drives the price of the stock up even further.

How often is Akari Therapeutics' short interest reported?

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including AKTX, twice per month. The most recent reporting period available is February, 28 2025.



Related Companies
Short Interest Tools

This page (NASDAQ:AKTX) was last updated on 3/14/2025 by MarketBeat.com Staff
From Our Partners
Nvidia’s CEO: “This Will Be a Multitrillion-Dollar Industry."
If you missed out on the big boom in Nvidia… Listen up, because according to Nvidia's own CEO… Elon Musk...
Brownstone Research | Sponsored
Trump Shock to change everything
Is this Trump’s next major move? Millionaire trading expert Imre Gams has found a bill that directs the Uni...
Centurion Publishing | Sponsored
DOGE could send 6 AI stocks through the roof
Stay alert for Elon Musk and the Department of Government Efficiency's next move … Expect an announcement f...
Weiss Ratings | Sponsored
“Amazon Coin” set to outperform Bitcoin
Chris Rowe – the man who recommended Amazon in 1998… Bitcoin and Ethereum in 2017… And has spotted 44 diffe...
True Market Insiders | Sponsored
BITCOIN
You're not going to believe this. There's a bizarre new way to make money from crypto... ...and it's not...
Awesomely, LLC | Sponsored
DOGE Social Security bombshell?
Elon Musk just dropped another bombshell... He revealed his DOGE organization has been taking aim at Social...
Altimetry | Sponsored
Trump's 100-Day Plan Triggers Global Retaliation
In the final days of his first term, Trump quietly left open an "off the books" wealth-protection loophole hid...
American Alternative | Sponsored
Elon Warns “America Is Broke”. Trump’s Plan Inside.
Elon Musk has avoided two major financial crises before. He pulled Tesla and SpaceX back from the brink of col...
American Hartford Gold | Sponsored